Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer of Nasopharynx
|
12 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2014 | 2014 | ||||||
Carcinogenesis
|
355 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2010 | 2010 | ||||||
Early infantile epileptic encephalopathy with suppression bursts
|
10 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2017 | 2017 | ||||||
Epithelial ovarian cancer
|
129 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2013 | 2013 | ||||||
Ichthyosis, X-Linked
|
10 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2013 | 2013 | ||||||
Malignant neoplasm of nasopharynx
|
10 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2014 | 2014 | ||||||
Opitz GBBB Syndrome, X-Linked
|
24 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2017 | 2017 | ||||||
Papillary thyroid carcinoma
|
204 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2018 | 2018 | ||||||
Steroid Sulfatase Deficiency Disease
|
5 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.010 | 1 | 2013 | 2013 | ||||||
Lip and Oral Cavity Carcinoma
|
172 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.333 | 3 | 2007 | 2013 | |||||
Malignant neoplasm of mouth
|
184 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.333 | 3 | 2007 | 2013 | |||||
Head and Neck Carcinoma
|
118 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.500 | 4 | 2011 | 2014 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.500 | 4 | 2011 | 2014 | |||||
Esophageal carcinoma
|
272 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 0.500 | 2 | 2008 | 2014 | |||||
Esophageal Neoplasms
|
270 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 0.500 | 2 | 2008 | 2014 | |||||
Malignant neoplasm of esophagus
|
214 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 0.500 | 2 | 2008 | 2014 | |||||
Malignant neoplasm of skin
|
38 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 0.500 | 2 | 2005 | 2014 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.050 | 0.600 | 5 | 2013 | 2017 | |||||
Childhood Osteosarcoma
|
151 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.080 | 0.625 | 8 | 2012 | 2018 | |||||
Osteosarcoma
|
178 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.080 | 0.625 | 8 | 2012 | 2018 | |||||
Osteosarcoma of bone
|
151 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.080 | 0.625 | 8 | 2012 | 2018 | |||||
Carcinoma, Basal Cell
|
91 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 1999 | 2005 | |||||
Cutaneous Melanoma
|
248 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 2013 | 2015 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 1999 | 2005 |